Civic AI
Civic AI
Procurement intelligence
SAM.gov36C26026Q0960
Open

Purchase of Rapid Syndromic Molecular Testing Reagents for Seattle VAMC

Response deadline
Sep 10, 2026
Due in 22 days
Date posted
Aug 19, 2026

Description

Our scope is to acquire specific FDA-approved infectious disease and oncology assays formulated as single-use test cartridges and reagents that are equal to and/or compatible to what is currently being used on the VA owned instrument/analyzer. Required rapid molecular assays include targets for C. difficile, SARS-CoV-2 with Influenza A & B and RSV, Strep A, MTB IVD – Mycobacterium tuberculosis with Rif, MVP-Multiplex Vaginal Panel, GI Panel, MRSA Carba-R, Norovirus, BCR-ABL, FII & FV and vanA PCR. The kit storage temperature should be 2 – 28°C and not require refrigeration. Time and date of delivery to be determined by the PSHCS Microbiology Department.

Classifications

Documents (1)

  • S02-36C26026Q0960.docx
    .docx229 KBNot yet available

Contacts

Similar contracts

Explore more